Researchers engineered a mutant form of IL-2 called “super-2” with increased binding affinity for IL-2Rβ, which avoided the interference of Treg cells and induced superior expansion as well as improved anti-cancer activities of NK cells [86]. Here, IL2 is linked to cancer.